| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 560.4 | 537.0 |
| Gross profit | 234.8 | 200.9 |
| Profit before tax | 36.2 | -2.5 |
| Net income | 26.8 | -3.4 |
| EPS (diluted, $ a share) | $1.07 | $-0.14 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +4.4% |
|---|---|
| Gross margin | 41.9% |
| Operating margin | 9.3% |
10-Q filed with the SEC, NASDAQ: ICUI. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Icu Medical Inc: key numbers
- Share price
- $176.91Close, Nov 17
- Market cap
- $4.42B
- Shares outstanding
- 25.01MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Icu Medical Inc
All →Icu Medical Insider Elisha W. Finney Sells $316K of Stock
Elisha W. Finney sold 1,765 shares of Icu Medical Inc at $179.00 a share, worth $316K in total between Nov 12, 2026 and Nov 13, 2026. Shares held after the trade: 4,871 (-25.9%).
- Value
- $316K
- Shares
- 1,765
- Average price
- $179.00
- Holding change
- -25.9%
- Trade date
- Nov 12, 2026 to Nov 13, 2026
Icu Medical Financial Results
ICU Medical reported Q3 2026 revenue of $560.4 million, up from $537.0 million in the prior year, with GAAP net income of $26.8 million compared to a net loss in the same period last year. The company reaffirmed its full-year 2026 guidance, noting it expects results to land at the high end of its previously stated ranges.
- Term
- Q3 2026
“Third quarter results were ahead of our expectations for Infusion Systems and generally in line with expectations for the remainder of the business.”
Vivek Jain, ICU Medical’s Chief Executive Officer